腹腔镜肝切除治疗转移性黑色素瘤的围手术期与肿瘤学结局
该单中心回顾性研究分析了2000年4月至2013年8月间11例黑色素瘤肝转移患者共13次腹腔镜肝切除的结局,共切除23个肝脏标本。中位手术时间137分钟,中位出血量少于50毫升,无术中不良事件及30天死亡。结论认为腹腔镜肝切除的围手术期并发症和长期生存与开腹肝切除相当。
要点
- 黑色素瘤肝转移行腹腔镜肝切除的围手术期并发症与长期生存与开腹肝切除相当。
- 本组无术中不良事件及30天死亡,中位出血量少于50毫升。
- 复发率高(91%,中位5个月),但部分患者可重复行腹腔镜肝切除。
核心结论
- 黑色素瘤肝转移行腹腔镜肝切除的围手术期并发症和长期生存与开腹肝切除相当,因腹腔镜疼痛轻、便于重复切除,可能优先选择腹腔镜。
研究设计与样本
- 单中心回顾性研究,纳入2000年4月至2013年8月在Oslo University Hospital-Rikshospitalet接受腹腔镜肝切除的11例黑色素瘤肝转移患者(1例皮肤、9例眼、1例原发灶不明),共13次手术。
- 术后并发症采用Accordion分类,生存分析采用Kaplan-Meier法。
主要发现
- 共切除23个肝脏标本,中位手术时间137(65-470)分钟,中位出血量少于50(<50-900)毫升。
- 无术中不良事件及30天死亡,中位随访33(9-92)个月。
- 1年、3年、5年总生存率分别为82%、45%和9%,中位总生存30(9-92)个月。
临床怎么用
- 对符合条件的黑色素瘤肝转移患者,可考虑腹腔镜肝切除,其围手术期并发症和长期生存与开腹肝切除相当。
- 术后需密切随访复发,因复发率高且中位复发时间短(5个月)。
- 对复发性肝转移,腹腔镜便于重复切除的优势可能支持其优先选择。
局限性
- 样本量小(11例患者、13次手术),为单中心回顾性研究,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stage IV metastatic melanoma carries a poor prognosis. In the case of melanoma liver metastasis (MLM), surgical resection may improve survival and represents a therapeutic option, with varying levels of success. Laparoscopic liver resection (LLR) for metastatic melanoma is poorly studied. The aim of this study was to analyze the outcomes of LLR in patients with MLM. MATERIALS AND METHODS: Between April 2000 and August 2013, 11 (1 cutaneous, 9 ocular and 1 unknown primary) patients underwent LLR for MLM at Oslo University Hospital-Rikshospitalet and 13 procedures in total were carried out. Perioperative and oncologic outcomes were analyzed. Postoperative morbidity was classified using the Accordion classification. Kaplan-Meier method was used for survival analysis. RESULTS: A total of 23 liver specimens were resected. The median operative time was 137 (65-470) min, while the median blood loss was less than 50 (<50-900) ml. No intraoperative unfavorable incidents and 30-day mortality occurred. Median follow-up was 33 (9-92) months. Ten patients (91%) developed recurrence within a median of 5 months (2-18 months) and two patients underwent repeat LLR for recurrent liver metastases. One-, three-, and five-year overall survival rates were 82, 45 and 9%, respectively. The median overall survival was 30 (9-92) months. CONCLUSION: Perioperative morbidity and long-term survival after LLR for MLM seems to be comparable to open liver resection. Thus, LLR may be preferred over open liver resection due to the well-known advantages of laparoscopy, such as reduced pain and improved possibility for repeated resections.
引用
- Aghayan DL, Kazaryan AM, Fretland ÅA, et al. Laparoscopic liver resection for metastatic melanoma. Surg Endosc. 2017. PMID: 28916919. doi:10.1007/s00464-017-5834-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。